Literature DB >> 1537607

Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance.

C A van Els1, J D'Amaro, J Pool, E Blokland, A Bakker, P J van Elsen, J J van Rood, E Goulmy.   

Abstract

Minor Histocompatibility (mH) antigens are polymorphic endogenously synthesized products that can be recognized by alloreactive T cells in the context of major histocompatibility complex molecules. In transplant situations where tissue donor and recipient are matched for HLA, mH antigens may trigger strong cellular immune responses. To gain insight into the polymorphism of mH antigens we studied their frequencies in the healthy population. Five HLA class I restricted mH antigens recognized by distinct cytotoxic T-cell (CTL) clones were used in the population genetic analysis consisting of a panel (N = 100) of HLA typed target cells. Three mH antigens showed phenotype frequencies of 69% or higher, this contrasted the frequencies of two other mH antigens with 16 and 7% respectively. To gain insight into the "functional" polymorphism of the T-cell response to mH antigens, we analyzed the specificity of CTL clones within individuals. Three out of five individuals investigated shared a CTL response to one single HLA-A2 restricted mH antigen. These results indicate limited allelic polymorphism for some mH antigens in the healthy population and are suggestive of the existence of immunodominant human mH antigens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537607     DOI: 10.1007/bf00185109

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  18 in total

1.  Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells.

Authors:  O Rötzschke; K Falk; K Deres; H Schild; M Norda; J Metzger; G Jung; H G Rammensee
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

Review 2.  Bone-marrow transplantation (first of two parts).

Authors:  E Thomas; R Storb; R A Clift; A Fefer; F L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

3.  Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme.

Authors:  S Demotz; H M Grey; E Appella; A Sette
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

4.  A gene-counting method of maximum likelihood for estimating gene frequencies in ABO and ABO-like systems.

Authors:  N Yasuda; M Kimura
Journal:  Ann Hum Genet       Date:  1968-05       Impact factor: 1.670

5.  Sequence and expression of transcripts of the human T-cell receptor beta-chain genes.

Authors:  Y Yoshikai; D Anatoniou; S P Clark; Y Yanagi; R Sangster; P Van den Elsen; C Terhorst; T W Mak
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

6.  Molecular analyses of in vivo hprt mutations in human T-lymphocytes. I. Studies of low frequency 'spontaneous' mutants by Southern blots.

Authors:  J A Nicklas; T C Hunter; L M Sullivan; J K Berman; J P O'Neill; R J Albertini
Journal:  Mutagenesis       Date:  1987-09       Impact factor: 3.000

7.  The non-MHC transplantation antigens: neither weak nor minor.

Authors:  B Loveland; E Simpson
Journal:  Immunol Today       Date:  1986 Jul-Aug

8.  Dominant T-cell receptor beta-chain gene rearrangements indicate clonal expansion in the rheumatoid joint.

Authors:  A M Miltenburg; J M van Laar; M R Daha; R R de Vries; P J van den Elsen; F C Breedveld
Journal:  Scand J Immunol       Date:  1990-01       Impact factor: 3.487

9.  Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. I. Absence of correlation with cytotoxic effector cells.

Authors:  C A van Els; A Bakker; A H Zwinderman; F E Zwaan; J J van Rood; E Goulmy
Journal:  Transplantation       Date:  1990-07       Impact factor: 4.939

10.  Detection of HLA restricted anti-minor histocompatibility antigen(s) reactive cells from skin GVHD lesions.

Authors:  N L Reinsmoen; J H Kersey; F H Bach
Journal:  Hum Immunol       Date:  1984-12       Impact factor: 2.850

View more
  21 in total

Review 1.  Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.

Authors:  Richard J O'Reilly; Tao Dao; Guenther Koehne; David Scheinberg; Ekaterina Doubrovina
Journal:  Semin Immunol       Date:  2010-05-26       Impact factor: 11.130

2.  Recognition of allo-peptide is governed by novel anchor imposition and limited variations in TCR contact residues.

Authors:  Corbett J A Reinbold; Subramaniam Malarkannan
Journal:  Mol Immunol       Date:  2007-11-05       Impact factor: 4.407

3.  CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.

Authors:  Ania Skowera; Richard J Ellis; Ruben Varela-Calviño; Sefina Arif; Guo Cai Huang; Cassie Van-Krinks; Anna Zaremba; Chloe Rackham; Jennifer S Allen; Timothy I M Tree; Min Zhao; Colin M Dayan; Andrew K Sewell; Wendy W Unger; Wendy Unger; Jan W Drijfhout; Ferry Ossendorp; Bart O Roep; Mark Peakman
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

4.  The genetic origin of minor histocompatibility antigens.

Authors:  D C Roopenian; G J Christianson; A P Davis; A R Zuberi; L E Mobraaten
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

5.  The CCR5 receptor acts as an alloantigen in CCR5Delta32 homozygous individuals: identification of chemokineand HIV-1-blocking human antibodies.

Authors:  H J Ditzel; M M Rosenkilde; P Garred; M Wang; K Koefoed; C Pedersen; D R Burton; T W Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

6.  A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells.

Authors:  Marleen M van Loenen; Renate de Boer; Ellis van Liempt; Pauline Meij; Inge Jedema; J H Frederik Falkenburg; Mirjam H M Heemskerk
Journal:  Haematologica       Date:  2013-12-13       Impact factor: 9.941

7.  Tissue distribution and polymorphism of minor histocompatibility antigens involved in GVHR.

Authors:  I Miconnet; V de la Selle; C Tucek; R Huchet; D Bonardelle; M Bruley-Rosset
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

Review 8.  T cell immunotherapeutic populations control viral infections in bone marrow transplant recipients.

Authors:  K S Slobod; E Benaim; L Woodruff; S Nooner; J Houston; M Holladay; T Lockey; J L Hurwitz
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

9.  A genetic analysis of human minor histocompatibility antigens demonstrates Mendelian segregation independent of HLA.

Authors:  G M Schreuder; J Pool; E Blokland; C van Els; A Bakker; J J van Rood; E Goulmy
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

10.  Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Pascale C van Weeren; Fatima Kazi; Annemieke Geluk; Nigel D L Savage; Jan W Drijfhout; Darren R Flower; Willem A Hanekom; Michèl R Klein; Tom H M Ottenhoff
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.